Progyny, Inc. (Nasdaq: PGNY) is a pioneering player in the field of women's health and family building. With the slogan, “A global women's health and family building company, trusted by leading employers and health plans,” Progyny has been transforming fertility benefits since its founding in 2008.
Headquartered in the United States, the company provides an all-encompassing solution that supports patients with personalized care—offering concierge support, coaching, and education. It connects users with a premier network of specialists utilizing the latest science and technologies to enhance clinical outcomes while mitigating costs for employers and patients alike.
Progyny has been recognized as a leader in the industry by accolades including TIME100 Most Influential Company and Forbes' Best Employers. Recently, it secured a significant $200.00M in Post IPO Debt financing as of 01 July 2025, further bolstering its financial stability and growth capacity.